02 Mar 2019 Pfizer Announces Serotypes Included in 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older
02 Mar 2019 Heat Biologics Presents Interim Phase 2 Lung Cancer Data on HS-110 + Nivolumab at ASCO-SITC Clinical Immuno-Oncology Symposium
28 Feb 2019 Novavax Announces Topline Results from Phase 3 PrepareTM Trial of ResVax™ for Prevention of RSV Disease in Infants via Maternal Immunization
15 Feb 2019 New Clinical Data Analysis Shows Survival Benefit Three Years after Treatment with Sipuleucel-T
14 Feb 2019 Advaxis Announces Enrollment of the First Patient in its Phase 1/2 Trial for ADXS-HOT in the Treatment of Non-Small Cell Lung Cancer
13 Feb 2019 Moderna Announces Positive Interim Phase 1 Data for First Combination Vaccine Against the Respiratory Viruses hMPV and PIV3
13 Feb 2019 Affinivax, Inc. Announces Initiation of Phase 1/2 Clinical Study of ASP3772, Its Novel Pneumococcal MAPS Vaccine, in Collaboration with Astellas
12 Feb 2019 FluGen’s M2SR Influenza Vaccine Succeeds in Phase 2 Human Challenge Trial Against a Highly Mismatched Virus
04 Feb 2019 VLP Therapeutics to Initiate First Clinical Trial of VLPM01 Malaria Vaccine
31 Jan 2019 Valneva Reports Positive Initial Booster Data and Final Phase 1 Data for its Lyme Disease Vaccine Candidate
30 Jan 2019 Merck Receives Breakthrough Therapy Designation from FDA for V114, the Company’s Investigational 15-Valent Conjugate Vaccine for the Prevention of Invasive Pneumococcal Disease, in Infants, Children, and Adolescents
29 Jan 2019 Takeda’s Dengue Vaccine Candidate Meets Primary Endpoint in Pivotal Phase 3 Efficacy Trial
24 Jan 2019 Advaxis’ Phase 3 AIM2CERV Study Placed on Partial Clinical Hold by FDA Related to CMC Requests
24 Jan 2019 Bavarian Nordic Advances Development of Equine Encephalitis Virus Vaccine
21 Jan 2019 ISA Pharmaceuticals Announces Start of Phase 2 Combination Trial of ISA101b and Regeneron’s Cemiplimab in Oropharyngeal Cancer
17 Jan 2019 United Neuroscience Announces Positive Top-Line Results from Phase 2a Clinical Study of UB-311 Vaccine in Patients with Alzheimer's Disease
17 Jan 2019 AIVITA Biomedical Receives IND Clearance for Phase 1B Melanoma Trial
17 Jan 2019 First Patient Dosed in Phase 1 Clinical Trial Evaluating Neoepitopes Formulated in IMV’s DPX Delivery Platform in Ovarian Cancer Patients
15 Jan 2019 FDA Approves Expanded Use of Adacel® (Tdap) Vaccine for Repeat Vaccination
08 Jan 2019 PrimeVax Immuno-Oncology Receives IND Permission From FDA
07 Jan 2019 Valneva Reports Positive Phase 1 Interim Results for Its Chikungunya Vaccine Candidate
03 Jan 2019 Genocea Doses First Patients and Completes Enrollment in Part A of Phase 1/2a Clinical Trial for Neoantigen Vaccine Candidate GEN-009
30 Dec 2018 Emergent BioSolutions Announces Submission to FDA of Application Covering Emergency Use Authorization for NuThrax
27 Dec 2018 FDA Approves VAXELIS(TM), Sanofi and MSD's Pediatric Hexavalent Combination Vaccine
22 Dec 2018 Aimmune Therapeutics Submits BLA to FDA for AR101 for the Treatment of Peanut Allergy in Children and Adolescents Ages 4–17

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up